Clotrimazole Loaded Ufosomes for Topical Delivery: Formulation Development and In-Vitro Studies

Global incidence of superficial fungal infections caused by dermatophytes is high and affects around 40 million people. It is the fourth most common cause of infection. Clotrimazole, a broad spectrum imidazole antifungal agent is widely used to treat fungal infections. Conventional topical formulati...

Full description

Bibliographic Details
Main Authors: Pradeep Kumar Bolla, Carlos A. Meraz, Victor A. Rodriguez, Isaac Deaguero, Mahima Singh, Venkata Kashyap Yellepeddi, Jwala Renukuntla
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/24/17/3139
_version_ 1818334300170354688
author Pradeep Kumar Bolla
Carlos A. Meraz
Victor A. Rodriguez
Isaac Deaguero
Mahima Singh
Venkata Kashyap Yellepeddi
Jwala Renukuntla
author_facet Pradeep Kumar Bolla
Carlos A. Meraz
Victor A. Rodriguez
Isaac Deaguero
Mahima Singh
Venkata Kashyap Yellepeddi
Jwala Renukuntla
author_sort Pradeep Kumar Bolla
collection DOAJ
description Global incidence of superficial fungal infections caused by dermatophytes is high and affects around 40 million people. It is the fourth most common cause of infection. Clotrimazole, a broad spectrum imidazole antifungal agent is widely used to treat fungal infections. Conventional topical formulations of clotrimazole are intended to treat infections by effective penetration of drugs into the stratum corneum. However, drawbacks such as poor dermal bioavailability, poor penetration, and variable drug levels limit the efficiency. The present study aims to load clotrimazole into ufosomes and evaluate its topical bioavailability. Clotrimazole loaded ufosomes were prepared using cholesterol and sodium oleate by thin film hydration technique and evaluated for size, polydispersity index, and entrapment efficiency to obtain optimized formulation. Optimized formulation was characterized using scanning electron microscopy (SEM), X-ray diffraction (XRD), and differential scanning calorimetry (DSC). Skin diffusion studies and tape-stripping were performed using human skin to determine the amount of clotrimazole accumulated in different layers of the skin. Results showed that the optimized formulation had vesicle size <250 nm with ~84% entrapment efficiency. XRD and DSC confirmed the entrapment of clotrimazole into ufosomes. No permeation was observed through the skin up to 24 h following the permeation studies. Tape-stripping revealed that ufosomes led to accumulation of more clotrimazole in the skin compared to marketed formulation (Perrigo). Overall, results revealed the capability of ufosomes in improving the skin bioavailability of clotrimazole.
first_indexed 2024-12-13T14:05:20Z
format Article
id doaj.art-c7969db2fbd54bc79412a43f831e785e
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-13T14:05:20Z
publishDate 2019-08-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-c7969db2fbd54bc79412a43f831e785e2022-12-21T23:42:37ZengMDPI AGMolecules1420-30492019-08-012417313910.3390/molecules24173139molecules24173139Clotrimazole Loaded Ufosomes for Topical Delivery: Formulation Development and In-Vitro StudiesPradeep Kumar Bolla0Carlos A. Meraz1Victor A. Rodriguez2Isaac Deaguero3Mahima Singh4Venkata Kashyap Yellepeddi5Jwala Renukuntla6Department of Biomedical Engineering, College of Engineering, The University of Texas at El Paso, 500 W University Ave, El Paso, TX 79968, USADepartment of Biomedical Engineering, College of Engineering, The University of Texas at El Paso, 500 W University Ave, El Paso, TX 79968, USADepartment of Biomedical Engineering, College of Engineering, The University of Texas at El Paso, 500 W University Ave, El Paso, TX 79968, USADepartment of Biomedical Engineering, College of Engineering, The University of Texas at El Paso, 500 W University Ave, El Paso, TX 79968, USADepartment of Pharmaceutical Sciences, University of the Sciences in Philadelphia, Philadelphia, PA 19104, USADivision of Clinical Pharmacology, Department of Pediatrics, University of Utah, Salt Lake City, UT 84112, USADepartment of Basic Pharmaceutical Sciences, Fred Wilson School of Pharmacy, High Point University, High Point, NC 27240, USAGlobal incidence of superficial fungal infections caused by dermatophytes is high and affects around 40 million people. It is the fourth most common cause of infection. Clotrimazole, a broad spectrum imidazole antifungal agent is widely used to treat fungal infections. Conventional topical formulations of clotrimazole are intended to treat infections by effective penetration of drugs into the stratum corneum. However, drawbacks such as poor dermal bioavailability, poor penetration, and variable drug levels limit the efficiency. The present study aims to load clotrimazole into ufosomes and evaluate its topical bioavailability. Clotrimazole loaded ufosomes were prepared using cholesterol and sodium oleate by thin film hydration technique and evaluated for size, polydispersity index, and entrapment efficiency to obtain optimized formulation. Optimized formulation was characterized using scanning electron microscopy (SEM), X-ray diffraction (XRD), and differential scanning calorimetry (DSC). Skin diffusion studies and tape-stripping were performed using human skin to determine the amount of clotrimazole accumulated in different layers of the skin. Results showed that the optimized formulation had vesicle size <250 nm with ~84% entrapment efficiency. XRD and DSC confirmed the entrapment of clotrimazole into ufosomes. No permeation was observed through the skin up to 24 h following the permeation studies. Tape-stripping revealed that ufosomes led to accumulation of more clotrimazole in the skin compared to marketed formulation (Perrigo). Overall, results revealed the capability of ufosomes in improving the skin bioavailability of clotrimazole.https://www.mdpi.com/1420-3049/24/17/3139ufosomesclotrimazoletopicalcholesteroltape-strippingpermegear flow-through diffusion cellssodium oleate
spellingShingle Pradeep Kumar Bolla
Carlos A. Meraz
Victor A. Rodriguez
Isaac Deaguero
Mahima Singh
Venkata Kashyap Yellepeddi
Jwala Renukuntla
Clotrimazole Loaded Ufosomes for Topical Delivery: Formulation Development and In-Vitro Studies
Molecules
ufosomes
clotrimazole
topical
cholesterol
tape-stripping
permegear flow-through diffusion cells
sodium oleate
title Clotrimazole Loaded Ufosomes for Topical Delivery: Formulation Development and In-Vitro Studies
title_full Clotrimazole Loaded Ufosomes for Topical Delivery: Formulation Development and In-Vitro Studies
title_fullStr Clotrimazole Loaded Ufosomes for Topical Delivery: Formulation Development and In-Vitro Studies
title_full_unstemmed Clotrimazole Loaded Ufosomes for Topical Delivery: Formulation Development and In-Vitro Studies
title_short Clotrimazole Loaded Ufosomes for Topical Delivery: Formulation Development and In-Vitro Studies
title_sort clotrimazole loaded ufosomes for topical delivery formulation development and in vitro studies
topic ufosomes
clotrimazole
topical
cholesterol
tape-stripping
permegear flow-through diffusion cells
sodium oleate
url https://www.mdpi.com/1420-3049/24/17/3139
work_keys_str_mv AT pradeepkumarbolla clotrimazoleloadedufosomesfortopicaldeliveryformulationdevelopmentandinvitrostudies
AT carlosameraz clotrimazoleloadedufosomesfortopicaldeliveryformulationdevelopmentandinvitrostudies
AT victorarodriguez clotrimazoleloadedufosomesfortopicaldeliveryformulationdevelopmentandinvitrostudies
AT isaacdeaguero clotrimazoleloadedufosomesfortopicaldeliveryformulationdevelopmentandinvitrostudies
AT mahimasingh clotrimazoleloadedufosomesfortopicaldeliveryformulationdevelopmentandinvitrostudies
AT venkatakashyapyellepeddi clotrimazoleloadedufosomesfortopicaldeliveryformulationdevelopmentandinvitrostudies
AT jwalarenukuntla clotrimazoleloadedufosomesfortopicaldeliveryformulationdevelopmentandinvitrostudies